Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
Open Access
- 22 May 2018
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 25 (8) , 2467-2474
Abstract
Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs)Keywords
Funding Information
- Ipsen Fund
This publication has 36 references indexed in Scilit:
- Are G3 ENETS neuroendocrine neoplasms heterogeneous?Endocrine-Related Cancer, 2013
- ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal NeoplasmsNeuroendocrinology, 2012
- The Pathologic Classification of Neuroendocrine TumorsPancreas, 2010
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patientsLaboratory Investigation, 2010
- A simplified prognostic system for resected pancreatic neuroendocrine neoplasmsHPB, 2009
- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumorsCancer, 2008
- Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreasBritish Journal of Surgery, 2008
- Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?Journal of Hepatology, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- The Ki-67 Protein: Fascinating Forms and an Unknown FunctionExperimental Cell Research, 2000